Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development
- PMID: 32033850
- PMCID: PMC7309563
- DOI: 10.1016/j.vaccine.2020.01.059
Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development
Abstract
Objective: Despite recommendations by professional organizations that all pregnant women receive inactivated influenza vaccine, safety concerns remain a barrier. Our objective was to assess the effect of trivalent influenza vaccines (IIV3) during pregnancy on parent report 6-month infant development.
Methods: We conducted a multi-site prospective birth cohort study during the 2010-2011 influenza season and followed pregnant women and their newborns through 6 months of age. Information on IIV3 during pregnancy was ascertained from the EHR and self-report. The Ages and Stages Questionnaire-3 (ASQ-3) was completed by the mother to assess 6-month infant neurodevelopment in five domains (communication, gross motor, fine motor, problem-solving, and personal adaptive skills). Scores for each domain above the cut-off point indicating typical development were categorized as "on schedule" while scores in the zones indicating the need for either monitoring or further assessment were categorized as "not on schedule". Multivariable logistic regression was conducted.
Results: Of the 1225 infant-mother pairs, 65% received IIV3 during pregnancy. In bivariate analysis, infants of women who received IIV3 during pregnancy were moderately-less likely to need monitoring or further assessment in the personal social domain compared with infants of unvaccinated women (10.0% vs. 14.1%, p = 0.033; crude OR (cOR): 0.68(95%CI:0.48,0.97)). However, after controlling for potential confounders, the findings were no longer statistically significant (aOR:0.72,95%CI: 0.49,1.06,p = 0.46). No significant unadjusted or adjusted associations emerged in any other ASQ-3 domain.
Conclusion: There was no significant association between IIV3 exposure during pregnancy and 6-month infant development. Studies of IIV3 during pregnancy to assess longer-term developmental outcomes are indicated.
Keywords: Ages and Stages (ASQ); Infant development; Pregnancy; Trivalent inactivated influenza vaccine (IIV3).
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Influenza vaccination of pregnant women and protection of their infants.N Engl J Med. 2014 Sep 4;371(10):918-31. doi: 10.1056/NEJMoa1401480. N Engl J Med. 2014. PMID: 25184864 Clinical Trial.
-
Efficacy of inactivated trivalent influenza vaccine in rural India: a 3-year cluster-randomised controlled trial.Lancet Glob Health. 2019 Jul;7(7):e940-e950. doi: 10.1016/S2214-109X(19)30079-8. Lancet Glob Health. 2019. PMID: 31200893 Free PMC article. Clinical Trial.
-
Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial.JAMA Netw Open. 2021 Jan 4;4(1):e2031266. doi: 10.1001/jamanetworkopen.2020.31266. JAMA Netw Open. 2021. PMID: 33443580 Free PMC article. Clinical Trial.
-
Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011 - 2019.Vaccine. 2020 Aug 18;38(37):5923-5926. doi: 10.1016/j.vaccine.2020.07.007. Epub 2020 Jul 21. Vaccine. 2020. PMID: 32709434 Review.
-
Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015.Vaccine. 2016 May 11;34(22):2507-12. doi: 10.1016/j.vaccine.2016.03.048. Epub 2016 Mar 23. Vaccine. 2016. PMID: 27015735 Free PMC article. Review.
Cited by
-
Maternal influenza vaccination and associated risk of fetal loss: A claims-based prospective cohort study.Vaccine. 2024 Dec 2;42(26):126256. doi: 10.1016/j.vaccine.2024.126256. Epub 2024 Sep 10. Vaccine. 2024. PMID: 39260053 Free PMC article.
-
Progress in the Development of Universal Influenza Vaccines.Viruses. 2020 Sep 17;12(9):1033. doi: 10.3390/v12091033. Viruses. 2020. PMID: 32957468 Free PMC article. Review.
-
Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review.Vaccine X. 2024 Feb 23;18:100464. doi: 10.1016/j.jvacx.2024.100464. eCollection 2024 Jun. Vaccine X. 2024. PMID: 38495929 Free PMC article. Review.
-
Maternal alcohol consumption during pregnancy and child development: Role of ADH1B and ALDH2 gene polymorphisms-The Yamanashi Adjunct Study of the Japan Environment and Children's Study.Alcohol Clin Exp Res (Hoboken). 2025 Jan;49(1):117-127. doi: 10.1111/acer.15487. Epub 2024 Nov 13. Alcohol Clin Exp Res (Hoboken). 2025. PMID: 39537314 Free PMC article.